Genotyping includes the detection or mapping process of small genetic. It is the process of studying DNA sequence to determine the genetic constitution in the genotypes of living organisms like humans, plants, animals, and microorganisms.The report study has analyzed revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers and market disrupters in the report and same is reflected in our analysis. Global Genotyping Market Drivers and Restraints: Technical advancements in the genotyping process are helping for miniaturization, automation, and reduction of the overall costs and operational flexibility. An increase in the technological advances in DNA sequencing like NGS is presenting rapid, accurate sequencing and high production, which are expected to drive the market growth. On the other hand, Genotyping instruments are prepared with advanced features and functionalities, which makes them an expensive cost. Pharmaceutical companies and research laboratories are requiring significant investments for procuring multiple, high-cost genotyping instruments. Also, maintenance costs and several other indirect expenses like sample and labor costs are some of the factors, which are increasing the overall cost. As a result, the high cost of the genotyping instruments is expected to limit the growth in the market. The technological advancements towards the development of innovative and efficient procedures for genotyping are expected to create lucrative opportunities for market key players. An introduction of automated sequencing models and high-throughput platforms deliver potential growth opportunities in the arena of clinical molecular modeling studies, new chemical entity interactions, and genome sequencing. The reagents & kits segment is expected to dominate the market during the forecast period (2020-2027). The dominant position in the market is attributed to the presence of the major high throughput platforms MiniSeq, MiSeq, iSeq, NextSeq, HiSeq X, and NovaSeq series from leading key players. Continuous developments in the enhancement of library preparation workflow are expected to drive the reagents & kits segment. Today, researchers have a wide variety of technologies for collecting genetic information. Array-based approaches are the method of choice in analyzing the genome for many plants and animals. As sequencing costs continue to decline, new approaches, which influence next-generation sequencing (NGS) technology is developing to perform genotyping studies. The sequencing segment is expected to share US $ XX Mn in the global genotyping market during the forecast period (2020-2027). The term next-generation sequencing-based genotyping (NGG) or sequence-based genotyping includes genotyping methods, which leverage NGS technology. NGG contains targeted, reduced representation, and hybridization-based approaches to determine and genotype SNPs in many individuals or specimens. The rapid development of sequencing technology has resulted in higher throughput and a lower cost per sample. The NGG is a cost-effective tool for genotype screening, genetic mapping, purity testing, screening backcross lines, constructing haplotype maps, and performing association mapping and genomic selection. The Diagnostic & Research Laboratories are expected to share significant growth in the genotyping market. The rise in penetration of high throughput technology-based diagnostic tests, which are CLIA waived or are under the process of clinical approval is expected to influence market growth. Region-wise, North America region is expected to contribute US $ XX Mn share in the global genotyping market. An increase in adoption of the technologically advanced genotyping products, presence of advanced healthcare infrastructure and developed healthcare systems in the US and Canada are expected to boost the growth in the market. Also, the existence of a large number of leading genotyping manufacturers, genotyping-based R&D projects, and rise in demand from pharmaceutical companies for genotyping products is some of the factors, which are responsible for the large share of the genotyping market in the region.